Skip to main content

Advertisement

SpringerLink
Log in

Myofascial Pelvic Pain: Rationale and Treatment

  • Pelvic Pain (C Payne and J Potts, Section Editors)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Chronic pelvic pain, in its many forms, commonly has a myofascial component that must be considered in the evaluation and treatment of women and men seeking medical care. Myofascial pain syndrome is a regional pain syndrome characterized by myofascial trigger points. At this time, the exact mechanism surrounding the formation of a trigger point is not known. Myofascial pelvic pain can develop as a result of a trigger point within the pelvic floor musculature or from extra-pelvic muscles that can refer into the pelvic region. Identification and appropriate therapeutic management of the myofascial trigger points is paramount to successful treatment of the pain and symptoms associated with chronic pelvic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Travell JG, Simons DG. myofascial pain and dysfunction: the trigger point manual. Volume 1: the upper extremities. Baltimore: Williams & Wilkins; 1983.

    Google Scholar 

  2. Why can’t my gynecologist diagnose me? The Bertice Berry Show. Executive producers; Kaplan B, Clements S. Twentieth Television Division of Fox Television, Twenty-First Century Fox Inc. Chicago, Illinois; October 28, 1993.

  3. Cahn S. Love and marriage. Barton Music Corp; Capitol Records. 1955.

  4. Fishbain DA, Goldberg M, Meagher BR, Steele R, Rosomoff H. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26:181–97.

    Article  CAS  PubMed  Google Scholar 

  5. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in a general internal medicine practice. West J Med. 1989;151:157–60.

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Hahn L. Chronic pelvic pain in women. A condition difficult to diagnose—more than 70 different diagnoses can be considered. Lakartidningen. 2001;98:1780–5.

    CAS  PubMed  Google Scholar 

  7. Berry SH, Elliott MN, Suttorp MJ, Bogart LM, Stoto MA, Eggers P, et al. The prevalence of symptoms of bladder pain syndrome/ interstitial cystitis among adult females in the United States. J Urol. 2011;186:540–4.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189:141–5.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Sibert L, Rigaud J, Delavierre D, Labat JJ. Chronic pelvic pain: epidemiology and economic impact. Prog Urol. 2010;20(12):872–85.

    Article  CAS  PubMed  Google Scholar 

  10. Landis JR, Williams DA, Clauw DJ, Naliboff BD, Robinson NA, van Bokhoven A. The MAPP research network: design, patient characterization and operations. BMC Urol. 2014;14:58. Very informative article regarding the NIH multidisciplinary research plans for chronic pelvic pain.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Simons DG, Travell JG, Simons LS. Travell and simons’ myofascial pain and dysfunction the trigger point manual. Vol. 1. Upper half of body. 2nd ed. Baltimore: Williams & Wilkins; 1999.

    Google Scholar 

  12. Simons DG. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol. 2004;14:95–107.

    Article  PubMed  Google Scholar 

  13. Ibarra JM, Ge HY, Wang C, Galan-del-Rio F, Alonso-Blanco C, Jimenez-Garcia R, et al. Latent myofascial trigger points are associated with an increased antagonistic muscle activity during agonist muscle contraction. J Pain. 2011;12:1282–8.

    Article  PubMed  Google Scholar 

  14. Ge HY, Zhang Y, Boudreau S, Yue SW, Arendt-Nielsen L. Induction of muscle cramps by nociceptive stimulation of latent myofascial trigger points. Exp Brain Res. 2008;187:623–8.

    Article  PubMed  Google Scholar 

  15. Gerwin RD, Dommerholt J, Shah JP. An expansion of Simons’ integrated hypothesis of trigger point formation. Curr Pain Headache Rep. 2004;8:468–75.

    Article  PubMed  Google Scholar 

  16. Bron C, Dommerholt JD. Etiology of myofascial trigger points. Curr Pain Headache Rep. 2012;16:439–44. Comprehensive review on the theories regarding trigger point formation.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Mense S, Gerwin RD, editors. Muscle pain: understanding the mechanisms. Berlin: Springer; 2010.

    Google Scholar 

  18. Doggweiler-Wigul R. Urologic myofascial pain syndromes. Curr Pain Headache Rep. 2004;8:445–51.

    Article  Google Scholar 

  19. Bassaly R, Tidwell N, Bertolino S, Hoyte L, Downes K, Hart S. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J. 2011;22:413–8.

    Article  PubMed  Google Scholar 

  20. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182:570–80.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Moldwin RM, Fariello JF. Myofascial trigger point of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14:409–17. Interesting report on the urologic approach to myofascial pelvic pain management including an in depth discussion of trigger point injections.

    Article  PubMed  Google Scholar 

  22. Schabrun SM, Hodges PW. Muscle pain differentially modulates short interval intracortical inhibition and intracortical facilitation in primary cortex. J Pain. 2005;13:187–94.

    Article  Google Scholar 

  23. Vidor LP, Torres ILS, Medeiros LF, Dussan-Sarria JA, Dall’Agnol L, Deitos A. Association of anxiety with intracortical inhibition and descending pain modulation in chronic myofascial pain syndrome. BMC Neurosci. 2014;15:42.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Hoffman D. Understanding multisymptom presentations in chronic pelvic pain: interrelationships between viscera and myofascial pelvic floor dysfunction. Curr Pain Headache Rep. 2011;15:343–6.

    Article  PubMed  Google Scholar 

  25. Pezzone MA, Liang R, Fraser MO. A model of neural cross-talk and irritation in the pelvic: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005;128:1953–64.

    Article  PubMed  Google Scholar 

  26. Head H. On disturbances of sensation with especial reference to the pain of visceral disease. Brain. 1893;18:1–133.

    Article  Google Scholar 

  27. MacKenzie J. Some points bearing on the association of sensory disorders and visceral disease. Brain. 1893;16:321–54.

    Article  Google Scholar 

  28. Warren JW, Morozov V, Howard FM, Wesselmann U, Gallicchio L, Langenberg P, et al. Before the onset of interstitial cystitis/bladder pain syndrome, the presence of multiple non-bladder syndromes is strongly associated with a history of multiple surgeries. J Psychosom Res. 2014;76:75–9.

    Article  PubMed  Google Scholar 

  29. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–S15. A comprehensive explanation of central sensitization.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Arendt-Nielsen L, Laursen RJ, Drewes AM. Referred pain as an indicator for neural plasticity. Prog Brain Res. 2000;129:343–56.

    Article  CAS  PubMed  Google Scholar 

  31. Xu Y, Ge HY, Arendt-Nielsen L. Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain. 2010;11:1348–55.

    Article  PubMed  Google Scholar 

  32. Fernandez-de-las-Penas C, Dommerholt J. Myofascial trigger points: peripheral of central phenomenon? Curr Rheumatol Rep. 2014;16:395. A well organized and informative discussion of the confusion around trigger points.

    Article  PubMed  Google Scholar 

  33. Steege JF, Siedhoff MT. Chronic pelvic pain. Obstet Gynecol. 2014;124:616–29.

    Article  PubMed  Google Scholar 

  34. Nelson P, Apt G, Justiz R, Brismee J, Dedrick G, Sizer Jr PS. Chronic female pelvic pain-part 2: differential diagnosis and management. Pain Pract. 2011;12:111–41.

    Article  PubMed  Google Scholar 

  35. Soares A, Andriolo RB, Atallah AN, da Silva EMK. Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev. 2014;(7). Art. No.:CD007533. doi:10.1002/14651858.CD007533.pub3.

  36. Adelowo A, Hacker MR, Shapiro A, Modest AM, Elkadry E. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Female Pelvic Med Reconstr Surg. 2013;19:288–92.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Nesbitt-Hawes EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A—single vs. repeat injections. Toxicon. 2013;63:83–7.

    Article  CAS  PubMed  Google Scholar 

  38. FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Nickel JC, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187:2113–8. One of two NIDDK funded RCTs to have the highest positive responder rate by treating the myofascial pain component of chronic pelvic pain.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Wesselmann U, Lai J. Mechanisms of referred visceral pain: uterine inflammation in the adult virgin rat results in neurogenic plasma extravasation in the skin. Pain. 1997;73:309–17.

    Article  CAS  PubMed  Google Scholar 

  40. Daenen L, Varkey E, Kellmann M, Nijs J. Exercise, not to exercise or how to exercise in patients with chronic pain? Applying science to practice. Clin J Pain. 2014; in press. An in-depth discussion of endogenous analgesia and dysfunctional endogenous analgesia.

  41. Ness TJ, Lloyd LK, Fillingim RB. An endogenous pain control system is altered in subjects with interstitial cystitis. J Urol. 2014;191:364–70.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Rhonda K. Kotarinos declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Rhonda Kotarinos Physical Therapy, Ltd., 1 TransAm Plaza, Suite 170, Oakbrook Terrace, IL, 60181, USA

    Rhonda K. Kotarinos

Authors
  1. Rhonda K. Kotarinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rhonda K. Kotarinos.

Additional information

This article is part of the Topical Collection on Pelvic Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kotarinos, R.K. Myofascial Pelvic Pain: Rationale and Treatment. Curr Bladder Dysfunct Rep 10, 87–94 (2015). https://doi.org/10.1007/s11884-014-0287-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-014-0287-y

Keywords

Search

Navigation